Crossmark

A new mission for an old anti-cancer drug: harnessing hepatocyte-specific metabolic pathways against liver tumors

Crossref DOI link: https://doi.org/10.1038/s41392-023-01513-5

Published Online: 2023-06-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liao, Weiting

Calvisi, Diego F. https://orcid.org/0000-0002-6038-8567
Chen, Xin https://orcid.org/0000-0002-9588-0164
License Information

Text and Data Mining valid from 2023-06-14

Version of Record valid from 2023-06-14
More Information

Article History

Received: 1 April 2023

Revised: 7 May 2023

Accepted: 21 May 2023

First Online: 14 June 2023

Competing interests

: The authors declare no competing interests.